Chris Kobylecki

Today is #WorldMSADay A day to raise awareness of multiple system atrophy. We want everyone to know about the support available to those affected by MSA and our work towards a world free of MSA. Share this post to raise awareness of MSA and to help ensure no one faces MSA alone.

Delighted to share our work, out today in @MDJ_Journal ! We highlight alpha-synuclein SAA positivity in PSP and CBS patient CSF samples. This may represent Lewy body co-pathology which can impact on clinical course (1/2) @PSPAssociation @MDC_IoN_UCL …mentdisorders.onlinelibrary.wiley.com/doi/10.1002/md…

Announcing the North of England Neurological Association #NENA meeting, November 29-30th 2024. Please consider submitting a research or case presentation. We look forward to welcoming you in Harrogate in November!

A diagnosis of MSA can be life-changing for a person and their family. This #MSAAwarenessWeek let's raise awareness of the physical impact of living with MSA. Please share this infographic from our 2022 Needs Survey demonstrating the difficulties of living with MSA.

Delighted to invite you to the MSA symposium 2024. Please book your tickets and meet an excellent group of speakers. This year, the focus is on early stages of MSA

Really important to spread the word about this invaluable on-line genetics resource and guidance for the neurology community and beyond. Be great to have some RTs. @NeuroPBL @chriskobylecki @TheNeuroAcademy @NEANU_2023

Today is #WorldMSADay - a day to raise awareness of multiple system atrophy worldwide & collaborate with other organisations like @MSACoalition towards a world free of MSA. Please share this post to raise awareness of MSA and to help ensure no one has to face MSA alone. #Share

We're excited to announce that we have launched our call for 2023-24 Research Project Grants. There is a focus on scientific research into MSA and improving the clinical care of people living with MSA. We'll inform you as soon as our Scientific Advisory Panel reaches its verdict.

Thanks to the @chiefpd2 team for this which arrived in the post today! Pleased to have made a contribution to this important #parkinsons trial and looking forward to the findings. Many thanks to the brilliant research team @MCCN_UK @NCAresearchNHS for their support of this trial

It's both #BrainAwarenessWeek and #MSAAwarenessWeek help us to spread awareness of this progressive neurological disorder that affects around 3,500 people in the UK and Ireland.Keep your eyes on our social media over the upcoming week for more information and ways to get involved

#HotOffThePress: We are pleased to share our second MSA Research Symposium blog. The afternoon was split into two sessions; Towards Improving Diagnosis and Prognosis of MSA and New Horizons in MSA Drug Trials. Our blog- msatrust.org.uk/blog/msa-resea…

We are pleased to share a blog on the first MSA Research Symposium hosted by MSA Trust and the UCL Institute of Neurology. Sessions focused on the latest basic science and clinical research into MSA. Our blog- msatrust.org.uk/blog/msa-resea…

Thanks Ed and thank you to all attendees for making this a successful meeting! Special thanks to my co-organiser @MontySilverdale, @TheTurnerAgency for invaluable support and all #ABN special interest group colleagues

Professor Michele Hu closing the meeting discussing stratified #biomarkers for #parkinsons, a potential key to success in clinical trials

Professor Niki Ray discussing #acetylcholine contribution to #gait in #parkinsons. Shout out to @chiefpd2 trial to which we are recruiting in Salford to inform potential treatment for falls

Fantastic tour through #dystonia from @DrSusanHFox to start the afternoon session of #ABN #movementdisorders meeting. Insights into pathophysiology, response to treatment and potential markers of treatment response. Many thanks Susan!

Thanks for your support and all the other sponsors! #movementdisorders

Great update on #tremor from Dr Sundus Alusi @WaltonCentre - evidence base for #ET, new therapies and the emerging evidence for efficacy and reducing adverse effects in #MRgFUS

Professor Oliver Bandmann introducing @UK_PD_CSG , an important development in delivery of clinical research and trials in #parkinsons

Professor Ed Wild kicking off #ABN #movementdisorders SIG with an update on #HD therapeutics with a star wars theme… @GJBrainResearch @theABN_Info